Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Re-activation of pulmonary tuberculosis during anti-programmed death-1 (PD-1) treatment.

× No keyword cloud information.

8 in total

1. Active and latent tuberculosis infections in patients treated with immune checkpoint inhibitors in a non-endemic tuberculosis area.

Authors: Gregory R Stroh; Tobias Peikert; Patricio Escalante
Journal: Cancer Immunol Immunother Date: 2021-03-26 Impact factor: 6.968

2. Increased Tuberculosis Incidence Due to Immunotherapy Based on PD-1 and PD-L1 Blockade: A Systematic Review and Meta-Analysis.

Authors: Kewei Liu; Dongpo Wang; Cong Yao; Min Qiao; Qing Li; Weicong Ren; Shanshan Li; Mengqiu Gao; Yu Pang
Journal: Front Immunol Date: 2022-05-19 Impact factor: 8.786

3. Tuberculosis Infection in a Patient Treated With Nivolumab for Non-small Cell Lung Cancer: Case Report and Literature Review.

Authors: Ronwyn van Eeden; Bernardo L Rapoport; Teresa Smit; Ronald Anderson
Journal: Front Oncol Date: 2019-07-24 Impact factor: 6.244

Review 4. Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations.

Authors: Amalia Anastasopoulou; Dimitrios C Ziogas; Michael Samarkos; John M Kirkwood; Helen Gogas
Journal: J Immunother Cancer Date: 2019-09-04 Impact factor: 13.751

5. Effect of administering subsequent immune checkpoint inhibition in cancer patients with prior COVID-19 infection.

Authors: Jianping Bi; Sheng Wang; Yajie Wang; Dongqin Yang; Vivek Verma; Jing Huang; Guang Han
Journal: J Infect Date: 2020-10-08 Impact factor: 6.072

6. Nivolumab Combined With Ipilimumab Treatment Induced Hypophysitis and Immune-Mediated Liver Injury in Advanced Esophageal Squamous Cell Carcinoma: A Case Report.

Authors: Yi Feng; Chengyang Li; Yuan Ji; Ying Liu; Lu Gan; Yiyi Yu; Tianshu Liu
Journal: Front Oncol Date: 2022-04-01 Impact factor: 5.738

Review 7. The dark side of immunotherapy.

Authors: Nwanneka Okwundu; Douglas Grossman; Siwen Hu-Lieskovan; Kenneth F Grossmann; Umang Swami
Journal: Ann Transl Med Date: 2021-06

8. Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α.

Authors: Liku B Tezera; Magdalena K Bielecka; Paul Ogongo; Naomi F Walker; Matthew Ellis; Diana J Garay-Baquero; Kristian Thomas; Michaela T Reichmann; David A Johnston; Katalin Andrea Wilkinson; Mohamed Ahmed; Sanjay Jogai; Suwan N Jayasinghe; Robert J Wilkinson; Salah Mansour; Gareth J Thomas; Christian H Ottensmeier; Alasdair Leslie; Paul T Elkington
Journal: Elife Date: 2020-02-24 Impact factor: 8.140

8 in total